Quality Chemical Industries Limited

Last updated
Quality Chemical Industries Limited
FormerlyCipla Quality Chemical Industries Limited - CiplaQCIL
Company typePublic
USE: Qcil
Industry Pharmaceutical Industry
FoundedJuly 10, 2005;19 years ago (2005-07-10)
Headquarters Luzira, Kampala, Uganda
Area served
Africa
Key people
Emmanuel Katongole
Executive Chairman
Ajay Kumar Pal
Chief Executive Officer
Products Pharmaceuticals
RevenueIncrease2.svg:USh265.3 billion (US$70.9 million) (March 2024) [1]
Total assets USh232.0 billion (US$60.1 million) (March 2024) [2]
Number of employees
360 (2024)
Website www.qcil.com

Quality Chemical Industries Limited (Qcil), formerly Cipla Quality Chemical Industries Limited (CiplaQCIL) is a pharmaceutical manufacturing company, established in Uganda by Ugandans in 2005. The company is committed to advancing wellness and is the largest producer of World Health Organization (WHO) pre-qualified HIV/AIDS and Malaria treatments in the region. According to a 2007 published report, Qcil was the only company in Africa to manufacture triple-combination antiretroviral (ARV) drugs. [3] Qcil currently produces TLD (a combination of tenofovir, lamivudine and dolutegravir), the latest first-line treatment used to treat and prevent HIV/AIDS. Qcil also manufactures antimalarials (ACTs), including Lumartem, containing artemisinin and lumefantrine, [4] and the Hepatitis B generic medicines Texavir and Zentair. [5] [6]

Contents

The company also manufactures antibacterials, anti-hypertensives, vasodilators, anti-emetics, antibiotics and antidiabetics.

Qcil’s state-of-the-art manufacturing facilities are GLP and cGMP-compliant, adhering to both national and international standards. The company has the following ISO certifications: 9001:2015, 14001:2015, and 45001:2018.

Location

Qcil's pharmaceutical manufacturing plant is located in Luzira, an industrial area in Nakawa Division in south-eastern Kampala. The plant is approximately 9 kilometres (6 mi), by road, south-east of Kampala's central business district. [7] The coordinates of the plant are 0°18'17.0"N, 32°38'22.0"E (Latitude:0.304723; Longitude:32.639436). [8]

Overview

As of 31 March 2024, the company's total assets were valued at USh232.0 billion (US$60.1 million), with associated EBITDA USh188.199 billion USh53.7 billion (US$14.4 million). [2]

History

In 2005, Quality Chemical Industries Limited was incorporated as a joint venture between, inter alia, Messrs. Emmanuel Katongole, Frederick Mutebi Kitaka and George Baguma (the Sponsors) and Cipla Limited (Cipla). The factory was commissioned in 2007.

In 2010, the company became the first WHO-prequalified facility in the region. Relevant products, such as ARVs and ACTs were also WHO-prequalified. In the same year, the company became the first in Africa to supply Global Fund with ACTs.

In 2014, Cipla acquired control of the company, and the company changed its name to Cipla Quality Chemical Industries Limited (CiplaQCIL).

In 2016, the company was converted to a public company. Two years later, in 2018, the company listed on the Uganda Securities Exchange, offering shares to individual and institutional investors in an Initial Public Offering (IPO).

In 2019, the company commissioned a new warehouse with a 5,000-pallet capacity. This was followed by the commissioning of a new laboratory in 2020.

In November 2023, Africa Capitalworks (ACW) acquired Cipla's 51.18% interest in the issued ordinary shares of the company. On 15 February 2024, the company changed its name to Quality Chemical Industries Limited (Qcil). [9]

As of March 2024, with a production capacity of approximately 1.2 billion pills per year, Qcil was trading with 13 African countries and had regulatory approval in 31 African countries.

Qcil announced record earnings and dividends in 2024.

As of 31 March 2024, the shareholding in the business was as follows: [10]

Quality Chemical Industries Limited (QCIL) Shareholding
ShareholderDomicileOwnership (%)Notes
Africa Capitalworks SSA 3 Mauritius
51.18
[10]
Amistad Limited United Kingdom
11.51
[10]
Capitalworks SSA 1Mauritius
11.15
[10]
Government Employees Pension Fund Uganda
8.54
[10]
NSSF Uganda Uganda
7.38
[10]
Emmanuel Katongole Uganda
2.79
[10]
Fredrick Mutebi Kitaka Uganda
2.79
[10]
George William Baguma Uganda
2.79
[10]
Joseph YigaUganda
0.11
[10]
Others
1.76
[10]
Total
100.00

Governance

Emmanuel Katongole is the Chairman of QCIL. He succeeded the late Francis Kitaka (1925 - 2021), one of the founding members and the first biochemist trained in East Africa. Katongole was previously the Managing Director of CiplaQCIL. The Chief Executive Officer of QCIL is Ajay Kumar Pal. [11]

Developments

As of October 2024, as reported by the Daily Monitor, QCIL was contemplating building a new US$50 million production line to manufacture anti-TB and anti-cancer medication. Potential willing funders include Standard Chartered Bank, USAID and the government of Italy. [12]

See also

Related Research Articles

<span class="mw-page-title-main">Port Bell</span> Place in Central Uganda, Uganda

Port Bell is a small industrial centre in the greater metropolitan Kampala area, in Uganda. Port Bell has a rail link and a railroad ferry wharf used for International traffic across Lake Victoria to Tanzania and Kenya.

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

Luzira is a suburb of Kampala, the capital of Uganda. It is best known for the country's main prison, Luzira Maximum Security Prison, which has seen significant redevelopment thanks to the work of African Prisons Project, a charity based in the UK and Kampala.

<span class="mw-page-title-main">Uganda Securities Exchange</span> Principal stock exchange of Uganda

The Uganda Securities Exchange (USE) is the principal stock exchange of Uganda. It was founded in June 1997. The USE is operated under the jurisdiction of Uganda's Capital Markets Authority, which in turn reports to the Bank of Uganda, Uganda's central bank.

Articles related to Uganda include:

<span class="mw-page-title-main">Uganda Communications Commission</span> Communications regulator of Uganda

The Uganda Communications Commission(UCC) is the government regulatory body of the communications sector in Uganda. Although owned by the Ugandan government, it acts independently. Its mandated responsibilities include licensing, regulation, communications infrastructure development and the expansion of rural communications service.

Nakawa Division is one of the five administrative divisions of the city of Kampala, the capital and largest city of Uganda. The town of Nakawa is the site of the division headquarters.

Butabika is a location in south-eastern Kampala, the capital city of Uganda.

Peter Ndimbirwe Mugyenyi is a Ugandan physician, HIV/AIDS researcher, medical administrator and author. He is executive director and co-founder of the Joint Clinical Research Centre, and a leading authority on treatment of HIV/AIDS in Africa.

Emmanuel Katongole, is a Ugandan statistician, economist, businessman, entrepreneur and industrialist. He is the executive chairman of Cipla Quality Chemical Industries Limited (CQCIL), the only company in Sub-Saharan Africa, that is authorized to manufacture triple-combination anti retro-viral drugs. Since 2014, he has also been the chairman of the Uganda National Oil Company.

Francis Xavier Kitaka was a Ugandan biochemist, veterinarian, entrepreneur and industrialist. He is the former chairman of Cipla Quality Chemical Industries Limited (CIPLAQCIL), located in Luzira, a suburb of Kampala, Uganda's capital and largest city. CIPLAQCIL is the only company in Sub-Saharan Africa, that is authorized to manufacture triple therapy antiretroviral drugs.

Frederick Mutebi Kitaka, is a Ugandan physicist, mathematician, accountant, entrepreneur, and industrialist. He is the executive director of finance at Quality Chemical Industries Limited (QCIL), a Ugandan limited liability company. QCIL is the only Sub-Saharan pharmaceutical company that is licensed to manufacture triple therapy antiretroviral medication. He is also a shareholder in the company and sits on its board of directors.

George W. Baguma, is a Ugandan businessman and entrepreneur. He is the current chief commercial officer and marketing director at Cipla Quality Chemical Industries Limited. George Baguma is a founder investor in QCIL and is a member of the company's board of directors.

Quality Chemicals Limited (QCL) is a Ugandan pharmaceutical, life sciences, and distribution company. The company was formed in 1997, specializing at first in the importation of generic human and veterinary medication. Its headquarters are located on Katwe Road, in the neighborhood known as Katwe in Makindye Division in the southern part of Kampala, Uganda's capital and largest city.

The Uganda National Oil Company (UNOC), also known as the National Oil Company of Uganda, is a limited liability petroleum company in Uganda owned by the Ugandan government. The 2013 Petroleum Act of Uganda provides for the establishment of the national oil company. UNOC's board of directors was inaugurated on 23 October 2015 by the president of Uganda.

The National Drug Authority (NDA) is a government-owned organisation in Uganda, mandated to regulate drugs in the country, including their manufacture, importation, distribution, and licensing.

The House of Dawda Group is a privately owned conglomerate in Uganda.

<span class="mw-page-title-main">Airtel Uganda</span> Ugandan telecommunications company

Airtel Uganda Limited is a mobile communications and information technology services provider in Uganda. The company also offers mobile funds transfer and banking services known as Airtel Payments Bank. Airtel Uganda Limited is a subsidiary of Airtel Africa PLC.

The Uganda Industrial Research Institute (UIRI) is a parastatal company, wholly owned by the government of Uganda, whose primary objective is to carry out scientific and industrial research, develop competitive technical services, improve the capacity and competence of indigenous entrepreneurs to embark on sustainable industrial production, to produce high quality marketable products, for the benefit of Uganda's citizens.

East African Medical Vitals Limited, commonly referred to as East African Medical Vitals (EAMV), is a manufacturer of consumable medical supplies in Uganda. It is reported to be the first company in Africa, that manufactures powder-free latex, medical gloves.

References

  1. Kabona Esiara (20 May 2024). "Uganda Drug Maker Dividend Up 120 Percent". The EastAfrican . Nairobi, Kenya. Retrieved 20 May 2024.
  2. 1 2 Quality Chemical Industries Limited (9 May 2024). "Quality Chemical Industries Limited: Audited Financial Statements For The Twelve Months Ended 31 March 2024" (PDF). Uganda Securities Exchange . Kampala, Uganda. Retrieved 20 May 2024.
  3. Wendo, Charles (6 October 2007). "ARVs Production Starts Monday". New Vision . Kampala. Retrieved 23 June 2014.
  4. Key, Data (2011). "Quality Chemical Industries, Uganda". Pharmaceutical Technology. Retrieved 23 June 2014.
  5. CiplaQCi (2015). "Timeline & Milestones". Ciplaqcil.co.ug. Retrieved 10 April 2016.
  6. CiplaQCi (December 2015). "Komboa Newsletter" (PDF). Ciplaqcil.co.ug. p. 4. Retrieved 10 April 2016.
  7. "Distance between Post Office Building, Kampala Road, Kampala, Central Region, Uganda and Cipla Quality Chemicals Industries Limited, Port Bell Road, Kampala, Central Region, Uganda" (Map). Google Maps . Retrieved 1 October 2021.
  8. "Location of Cipla Quality Chemical Industries Limited Pharmaceutical Factory, Luzira, Nakawa Division, Kampala, Uganda" (Map). Google Maps . Retrieved 11 July 2016.
  9. Deogratius Wamala (26 February 2024). "Quality Chemical drops Cipla name". Daily Monitor . Kampala, Uganda. Retrieved 27 February 2024.
  10. 1 2 3 4 5 6 7 8 9 10 11 Deogratius Wamala (23 November 2023). "Delayed Cipla exit plan costs Quality Chemical Shs20b". Daily Monitor . Kampala, Uganda. Retrieved 26 November 2023.
  11. Aloysius Kasoma (19 August 2022). "Cipla-QCIL Pays First Dividend To Shareholders After 4 years". New Vision . Kampala, Uganda. Retrieved 26 October 2024.
  12. Deogratius Wamala (14 October 2024). "Quality Chemical to set up $50m TB, cancer drugs plant". Daily Monitor . Kampala, Uganda. Retrieved 26 October 2024.

00°18′17″N32°38′22″E / 0.30472°N 32.63944°E / 0.30472; 32.63944